monoclonal antibody targeting amylin (ProMIS Neurosciences)

N/A

Report date: 2025/03/20 14:50:08

Base Information

Drug Namemonoclonal antibody targeting amylin (ProMIS Neurosciences)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionIslet amyloid polypeptide modulators
TargetsIslet amyloid polypeptide
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProMIS Neurosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesProMIS Neurosciences Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A